These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effect of storage temperature on the stability of Lassa virus complement-fixing antigen. Tomori O Bull World Health Organ; 1980; 58(2):293-6. PubMed ID: 6772319 [TBL] [Abstract][Full Text] [Related]
44. [Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever]. Firsova IV; Shatokhina IV; Borisevich IV; Evseev AA; Maksimov VA; Pantiukhov VB; Khmelev AL Vopr Virusol; 2003; 48(6):43-5. PubMed ID: 14708232 [TBL] [Abstract][Full Text] [Related]
45. [Sensitivity and specificity of erythrocyte baculovirus diagnostic agents in the passive hemagglutination reaction]. Gural' AL Mikrobiol Zh (1978); 1983; 45(6):81-5. PubMed ID: 6400789 [No Abstract] [Full Text] [Related]
46. [The coagglutination reaction with arbo- and arenaviruses]. Skofertsa PG; Stepanova OA; Sveshnikova NA; Gaĭdamovich SIa Vopr Virusol; 1988; 33(6):755-60. PubMed ID: 2470204 [No Abstract] [Full Text] [Related]
47. Detection of poliovirus antigens and antibodies: microindirect haemagglutination and haemagglutination inhibition tests for poliovirus types I, II, and III. Esposito JJ Microbios; 1976; 16(63):29-36. PubMed ID: 194134 [TBL] [Abstract][Full Text] [Related]
48. [Elaboration of erythrocyte preparations for antigen and antibody detection in the indirect hemagglutination test]. Konikova RE; Noskov FS; Baiar GA Tr Inst Im Pastera; 1981; 56():13-31. PubMed ID: 6764967 [No Abstract] [Full Text] [Related]
49. [Experience with using the indirect hemagglutination reaction in studying natural foci of tick-borne encephalitis]. Nikolaev VP; Shmidt OA Vopr Virusol; 1983; (3):313-5. PubMed ID: 6613088 [TBL] [Abstract][Full Text] [Related]
50. [Production of infectious virus and the accumulation in Vero cells of Pichinde virus antigens detectable by an indirect fluorescent antibody method]. Kunitskaia LIa; Zaĭtseva VN; Vladyko AS; Novokhatskiĭ AS Vopr Virusol; 1986; 31(4):493-8. PubMed ID: 3020808 [TBL] [Abstract][Full Text] [Related]
51. [Protection induced in guinea pigs by the variant XJ0 of Junin virus]. Boxaca MC; de Guerrero LB; Weber EL; Malumbres E Medicina (B Aires); 1981; 41(1):25-34. PubMed ID: 6267412 [No Abstract] [Full Text] [Related]
52. [Experimental evaluation of the pathogenicity of Lassa virus variants]. Vladyko AS; Surikova LE; Vovk TA; Cherednichenko IA; Torop AV Vopr Virusol; 1985; 30(4):454-7. PubMed ID: 4060702 [TBL] [Abstract][Full Text] [Related]
53. [An evaluation of the possibility of obtaining an inactivated vaccine against Lassa fever]. Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):74-5. PubMed ID: 7879553 [No Abstract] [Full Text] [Related]
54. [The direct and indirect hemagglutination test with Sumakh-Ukuniemi virus]. Kiriushchenko TV; Gaĭdamovich SIa Vopr Virusol; 1973; 18(1):117-22. PubMed ID: 4799694 [No Abstract] [Full Text] [Related]